Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Hemangiosarcoma × Watchful Waiting × Clear all

Status

Recruiting 1 Completed 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 7 Breast Neoplasms 3 Thyroid Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Lymphoma, Large B-Cell, Diffuse 2 Leukemia 2 Esophageal Neoplasms 2 Brain Neoplasms 2 Urinary Bladder Neoplasms 1 Thyroid Nodule 1 Thrombocythemia, Essential 1 Retinoblastoma 1 Primary Myelofibrosis 1 Polycythemia Vera 1 Pleuropulmonary blastoma 1 Papillary Thyroid Microcarcinoma 1 Neoplasms 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1 Meningioma 1 Mastocytosis 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, T-Cell 1 Lymphoma, Mantle-Cell 1 Lung Neoplasms 1 Liver Neoplasms 1 Leukemia, Myelomonocytic, Juvenile 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1

Interventions

pembrolizumab 4 Standard of Care 2 Doxorubicin 2 zanidatamab 1 veliparib 1 tucatinib 1 trilaciclib 1 trebananib 1 trastuzumab duocarmazine 1 talazoparib 1 spartalizumab 1 selinexor 1 sarilumab 1 regorafenib 1 pexidartinib 1 pertuzumab 1 pazopanib 1 patritumab 1 olaparib 1 niraparib 1 neratinib 1 ganitumab 1 durvalumab 1 dostarlimab 1 cemiplimab 1 abemaciclib 1 Watchful Waiting 1 Trastuzumab 1 STA 9090 1 SGN-LIV1A 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06375941 2025-11-20

ProStars

Italian Sarcoma Group

Hemangiosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡